Observational Study on the Patients With Pain Medications - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

October 10, 2008

Last Updated Date

October 10, 2008

Start Date ^†

Current Primary Outcome Measures ^†

Original Primary Outcome Measures ^†

Change History

No Changes Posted

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Observational Study on the Patients With Pain Medications

Official Title ^†

Observational Study on the Patients With Pain Medications

Brief Summary

This is a Phase IV, Multi-center, Non-interventional, Observational Study to describe the usage of pain treatment, the demographics, clinical characteristics of pain patients, current treatments, the outcomes, reason of switch of the medication during pain treatment in Taiwan.

Detailed Description

This is a Phase IV, Multi-center, Non-interventional, prospective observational study to describe the usage of pain treatment, the demographics, clinical characteristics of pain patients, current treatments, the outcomes, and reason of switching of the medication during pain treatment in Taiwan in order to gain understanding the Taiwan pain control status. Precise estimates of the prevalence of different pain syndromes in the Taiwan are difficult to ascertain. In Taiwan, there are no approved documentations could show the most effect standard medication for treatment in pain patients currently. The data will be collected at baseline and every 2 weeks for 2 months. Safety data will not be collected unless the patients have taken Johnson & Johnson's medication and have serious adverse event.

Observational study with no study medication administered.

Study Phase

Phase IV

Study Type ^†

Observational

Study Design ^†

Prospective

Condition ^†

Pain

Intervention ^†

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Active, not recruiting

Enrollment ^†

2500

Completion Date

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

Outpatients
Patients must have pain, previously treated with/without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time
Patient must have a VAS score >4

Exclusion Criteria:

Patients who are receiving any investigational drug during the study
Patients with known or suspected for psychotic disease or mental retardation

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00771212

Responsible Party

Secondary IDs ^††

Study Sponsor ^†

Johnson & Johnson Taiwan Ltd

Collaborators ^††

Investigators ^†

Study Director:

Johnson & Johnson Taiwan, Ltd. Clinical Trial

Johnson & Johnson Taiwan Ltd

Information Provided By

Johnson & Johnson Taiwan Ltd

Verification Date

October 2008

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.